Fludzoparib" and Anti-angiogenic
1 clinical trials · Condition
◉ Watch Fludzoparib" and Anti-angiogenic
| Record | Firm | Date |
|---|---|---|
| Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer (NCT06255392) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-06-12 |
Track Fludzoparib" and Anti-angiogenic automatically
Every clearance here is in the API, with alerts when new ones post.